Globus Medical Inc - Ordinary Shares - Class A
GMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.93B
Close$
$221.63
172.2% upside
Current Fair Value
172.2% upsideUndervalued by 172.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.93 Billion |
|---|---|
| Enterprise Value | $10.57 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.98 |
| Beta | 0.96 |
| Outstanding Shares | 135,364,000 |
Return
| Return on Equity | 11.23% |
|---|---|
| Return on Assets | 9.76% |
| Return on Invested Capital | 13.01% |
Valuation & Multiples
| P/E Ratio | 20.51 |
|---|---|
| PEG | -81.12 |
| Price to Sales | 3.54 |
| Price to Book Ratio | 2.33 |
| Enterprise Value to Revenue | 3.36 |
| Enterprise Value to EBIT | 16.22 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.10
Average shareholder expectationRevenue Estimate
$782.88 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$1.20
Average shareholder expectationRevenue Estimate
$792.44 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 19.40% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.28%▼ 87.52% |
|---|---|
| Total Invested | $128.73M▼ 98.65% |
| Investors Holding | 60▼ 555.00% |
ESG Score
No data
About Globus Medical Inc
CEO: David Demski